Marnelli A. Bautista-Quach
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marnelli A. Bautista-Quach has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Anna B. Pawlowska
Pediatric Hematopoietic Cell Transplantation Program, Department of Pediatrics City of Hope National Medical Center Duarte California USA
1 shared publication Auayporn Nademanee
1 shared publicationDennis D. Weisenburger
1 shared publicationHuiqing Wu
1 shared publication- Karen L. Chang
Department of Pathology, City of Hope National Medical Center, Duarte, California 91010, USA
1 shared publication Karl Gaal
1 shared publication
Latest Publications
- 1 December 2013
- Published by Elsevier in Clinical Breast Cancer
- Vol. 13 (6) , 492-495
Implant-Associated Primary Anaplastic Large-Cell Lymphoma With Simultaneous Involvement of Bilateral Breast Capsules
- 1 December 2013
- Published by Elsevier in Clinical Breast Cancer
- Vol. 13 (6) , 492-495
Implant-Associated Primary Anaplastic Large-Cell Lymphoma With Simultaneous Involvement of Bilateral Breast Capsules
- 1 March 2013
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 37 (3) , 453-458
Pediatric Mast Cell Sarcoma of Temporal Bone With Novel L799F (2395 C>T) KIT Mutation, Mimicking Histiocytic Neoplasm
Mast cell sarcoma (MCS) is an extremely rare neoplasm with a clinically aggressive course. Because of its rarity, its morphologic and molecular characteristics are still not well defined. We report a case of a 15-year-old girl with MCS of the temporal bone extending into the posterior fossa creating a mass effect. The lesion mimicked a histiocytic neoplasm morphologically, but showed a novel KIT missense mutation, L799F (2395 C>T). The KIT D816V mutation is frequently found in systemic mastocytosis, but it has not been documented in the few reported human MCS cases. However, 1 reported case of MCS has shown a different alteration in the KIT gene. Our case is the first MCS case with L799F mutation, located between the catalytic loop (790 to 797) and the activation loop (810 to 837) of the KIT gene, and only the second case of MCS with KIT mutation documented in the literature. Proximity of the L799F mutation to the enzymatic region of the KIT tyrosine kinase domain may induce resistance to tyrosine kinase inhibitors.
- 1 March 2013
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 37 (3) , 453-458
Pediatric Mast Cell Sarcoma of Temporal Bone With Novel L799F (2395 C>T) KIT Mutation, Mimicking Histiocytic Neoplasm
Mast cell sarcoma (MCS) is an extremely rare neoplasm with a clinically aggressive course. Because of its rarity, its morphologic and molecular characteristics are still not well defined. We report a case of a 15-year-old girl with MCS of the temporal bone extending into the posterior fossa creating a mass effect. The lesion mimicked a histiocytic neoplasm morphologically, but showed a novel KIT missense mutation, L799F (2395 C>T). The KIT D816V mutation is frequently found in systemic mastocytosis, but it has not been documented in the few reported human MCS cases. However, 1 reported case of MCS has shown a different alteration in the KIT gene. Our case is the first MCS case with L799F mutation, located between the catalytic loop (790 to 797) and the activation loop (810 to 837) of the KIT gene, and only the second case of MCS with KIT mutation documented in the literature. Proximity of the L799F mutation to the enzymatic region of the KIT tyrosine kinase domain may induce resistance to tyrosine kinase inhibitors.